SCHEMBL9728169

SCHEMBL9728169

CC(C)C(c1ccc(NC(=O)Cc2cccc(F)c2)c([N+](=O)[O-])c1)n1ccnc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.41
PKM P14618 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
ALDH1A1 P00352 4/20 0.40
MAPK1 P28482 1/20 0.40
ROCK2 O75116 1/20 0.39
KMT2A Q03164 2/20 0.39
KCNQ2 O43526 1/20 0.38
LMNA P02545 2/20 0.38
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
ANO1 Q5XXA6 1/20 0.38
CYP17A1 P05093 1/20 0.37
RECQL P46063 1/20 0.37
PRKACA P17612 1/20 0.37
ROCK1 Q13464 1/20 0.37
CES2 O00748 1/20 0.37
CYP26A1 O43174 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9196029 0.91 L3MBTL1 (0.51) MAPTPKML3MBTL1ALDH1A1MAPK1
SCHEMBL9728699 0.90 KCNQ2 (0.41) MAPTPKML3MBTL1ALDH1A1MAPK1
SCHEMBL9728372 0.85 MAPT (0.41) MAPTPKML3MBTL1ALDH1A1MAPK1
SCHEMBL9728217 0.84 CYP17A1 (0.45) MAPTPKML3MBTL1KMT2AHTT
SCHEMBL9191000 0.81 CYP17A1 (0.44) MAPTALDH1A1MAPK1KMT2AHTT
SCHEMBL10582410 0.81 MAPT (0.46) MAPTPKMKMT2AHTTCYP17A1
Fluorobenzene SCHEMBL10576700 0.80 CYP17A1 (0.48) HTTCYP17A1CYP26A1CYP3A4
SCHEMBL10698157 0.78 MAPT (0.46) MAPTL3MBTL1ALDH1A1KMT2ALMNA
SCHEMBL10577494 0.78 CYP17A1 (0.48) MAPTPKML3MBTL1ALDH1A1MAPK1
SCHEMBL9728006 0.77 CYP17A1 (0.47) KMT2AHTTCYP17A1CYP26A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1036003-C A process for preparing (1H-azol-1-ylmethyl) substituted quinoxaline derivatives JANSSEN PHARMACEUTICA NV (BE) 1997-10-01 CN disclosed
CN-1033752-C (1H-azol-1-ylmethyl) substituted quinoline or quinolinone derivatives JANSSEN PHARMACEUTICA NV (SE) 1997-01-08 CN disclosed
US-5151421-A Compounds for inhibition of metabolism of retinoids, for treatment for proliferation of epithelial cells and keratin disorders JANSSEN PHARMACEUTICA N.V. (BE) 1992-09-29 US disclosed
US-5028606-A Retinoid metabolism inhibitors JANSSEN PHARMACEUTICA N.V. (BE) 1991-07-02 US disclosed